YOCRC survivor: Get your symptoms checked
Young-Onset Colorectal Cancer/BRAVE-CRC Program
Colorectal cancer is on the rise among young people in the U.S. Nearly one in nine new colon cancer cases and one in five new rectal cancer cases occur in people under age 50. The Young-Onset Colorectal Cancer Program provides care and support tailored to these patients.
The program connects young-onset colon and rectal cancer patients with a team of physicians and other healthcare professions from one of the nation’s top-ranked cancer centers.
This team provides personalized care starting at diagnosis, continuing onto treatment and into survivorship. It includes the most advanced therapies along with services that help patients age 50 and under manage the impact of cancer on their lives.
Support for younger patients
A team of colorectal cancer specialists, including a surgeon, radiation oncologist and medical oncologist, work together to develop treatment plans for each patient. Prior to planning, patients undergo tests that determine the unique molecular profile of their disease. This information helps doctors choose the most effective treatments possible.
The program also offers a dedicated care coordinator who talks with patients about their values, preferences and concerns. The coordinator then connects patients to UT MD Anderson services that address these issues.
These services include:
- Genetic counseling and testing for patients and their family.
- A high-risk genetics clinic for patients and families that test positive for a hereditary cancer syndrome.
- An oncofertility program for men and women whose fertility may be affected by cancer and its treatments.
- Supportive care, which offers support in areas such as mental health, self-care, sexual health and parenting.
- A clinic dedicated to helping patients with their ostomy and wound care needs.
- Social work counseling, which can include help adjusting to a cancer diagnosis; talking to children about cancer; and addressing finances, employment and insurance issues.
- Opportunities to connect with other cancer patients through support groups, the Adolescent and Young Adult Program and myCancerConnection.
- Rehabilitation services, including physical therapy and pelvic floor therapy.
- Integrative medicine services, such as music therapy, nutrition counseling, oncology massage and yoga therapy.
Clinical trials and research
As a leading cancer center, UT MD Anderson develops new approaches that improve patient outcomes and quality of life. Patients in the program can impact the entire field of young-onset colorectal cancer by participating in clinical trials and research.
All patients with the program are invited to participate in the Young-onset Colorectal Cancer Health Outcomes Study (YOU-ROC). This study tracks patients throughout diagnosis, treatment and cancer survivorship. It focuses on:
- Cancer risk factors.
- Quality of life and patient-reported outcomes.
- Cancer monitoring and surveillance.
UT MD Anderson also offers a number of colon cancer and rectal cancer clinical trials. Patients may be offered the chance to participate in these studies. Research areas include:
- Treatment sequencing or decision-making based on molecular profiling.
- New technologies or tests to treat or detect cancer.
- New cancer drugs, including targeted therapies and immunotherapies.
Program Appointments
To request an appointment, new patients should visit UT MD Anderson's Appointments page. Existing patients should ask a provider for a referral to the Young-Onset Colorectal Cancer Program.
Featured Podcast:
Colon cancer and young adults
Colon cancer is on the rise among young adults in the United States. What do you need to know about the disease, and who is it affecting?
2026 patient conference
About the conference
The Annual YOCRC Patient Conference to bring together YOCRC patients, survivors and caregivers from Texas, across the nation and internationally. The participants will advance their understanding of YOCRC, its genetic and non-genetic risk factors, stage-specific treatments, as well as the multi-dimensional impact of living with YOCRC. Participants will network with leading clinicians, researchers, patient advocates, and most importantly, each other. This conference is dedicated to educating and empowering YOCRC patients, with the message that we are with you every step of the way.
Conference date & registration
The conference is scheduled for April 25, 2026 from 9 a.m.-3 p.m. Central Time.
This is a virtual confereence held online. Register for the Annual YOCRC Patient Conference.
Target audience
The primary target audience includes YOCRC patients, families and caregivers, while the entire colorectal cancer community is invited to tune into this virtual conference.
Objectives
- To understand recent advances in local and systemic therapies in young- onset Colorectal cancer.
- To equip patients, caregivers, and providers to engage in shared treatment decision-makingin the setting of multidisciplinary care.
- To present integrative and transformative strategies for managing multi- dimensional needs along the cancer journey.
- To provide an opportunity for patients to network with each other, and with healthcare providers and to enhance support by building a patient community.
Conference agenda
Time |
Title |
9-9:05 a.m. |
Welcome and Introduction
|
| 9:05- 0:50 a.m | Hot Topics in Colorectal Cancer (CRC) CtDNA and Surveillance, Arvind Dasari, M.D. Watch & Wait Approach in Rectal Cancer, Joshua Smith, M.D. Colorectal Liver Metastasis (CLM) and Targeted Liver Therapies, Adriana Gamboa, M.D. Promising Trials in CRC - S. Daniel Haldar, M.D. |
| 10:45-11 a.m. | Break |
| 11-12 p.m. | Keynote: Sweat, Science, Spandex and Cancer: The Story of the CHALLENGE Trial Christopher Booth, M.D. FRCPC
|
| 12-1 p.m. | Moderated Lunch/Chat Questions |
| 1-2 p.m. |
Multidisciplinary Tumor Board |
| 2-2:45 p.m. | Survivorship Hour Pelvic Floor Health in Rectal Cancer, Jeongyoon Moon, M.D. Living Beyond Cancer, Allison Rosen |
| 2:45-3 p.m | Closing Remarks Victoria Higbie, M.D. |
Featured speaker
Christopher Booth, M.D., FRCPC, is a medical oncologist and health services researcher at Queen’s University in Kingston, Canada. He is professor of oncology and public health sciences and director of the Division of Cancer Care and Epidemiology at the Sinclair Cancer Research Institute. His clinical practice focuses on GI cancers, and his research examines access, quality and value in cancer care.
Booth has published over 400 peer-reviewed manuscripts and advises the World Health Organization on global cancer policy. He previously held the Canada Research Chair in Population Cancer Care (2014–2024) and co-chaired the Canadian Cancer Trials Group CO.21 CHALLENGE trial, published in the New England Journal of Medicine in 2025. He received the Exceptional Healer Award in 2022 and is a Fellow of the Canadian Academy of Health Sciences, as well as a founding leader of the Common Sense Oncology initiative.
UT MD Anderson faculty presenters
Grace Smith, M.D., Ph.D., M.P.H.
Associate Professor, Gastrointestinal Radiation Oncology
Bruno Odisio, M.D.
Assistant Professor, Interventional Radiology
Ryan Huey, M.D.
Associate Professor, Gastrointestinal Medical Oncology
Arvind Dasari, M.D.
Professor, Gastrointestinal Medical Oncology
S. Daniel Haldar, M.D.
Assistant Professor, Gastrointestinal Medical Oncology
Adriana Gamboa, M.D.
Assistant Professor, Surgical Oncology
Timothy Newhook, M.D.
Assistant Professor, Surgical Oncology
Paula Smith, M.D., Ph.D.
Assistant Professor, Colon & Rectal Surgery
Jeongyoon (Jenny) Moon, M.D.
Assistant Professor, Colon & Rectal Surgery
J. Joshua Smith, M.D., Ph.D., FACS
Professor and Chair, Colon & Rectal Surgery
Montserrat Guraieb-Trueba, M.D.
Assistant Professor, Colon & Rectal Surgery
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.